Generate a tailored SOP for Dr. Peter Quinn. Improve your application with a focused, well-structured draft.
Peter M.J. Quinn is an Assistant Professor at the Perelman School of Medicine at the University of Pennsylvania, specializing in the field of ophthalmology. His research focuses on understanding the mechanisms underlying retinal degenerative diseases and developing novel therapeutic strategies. With an educational background that includes a BSc in Biological Sciences from the University of Manchester, an MSc in Molecular Medicine Cancer Research from Brunel University, and a PhD from the Leiden University Medical Center, Dr. Quinn has been actively involved in groundbreaking research. His expertise encompasses areas such as neurodegeneration and gene therapy, alongside advanced techniques like CRISPR/Cas gene editing and the use of induced pluripotent stem cells (iPSCs) to create organoid models. His current projects aim to create gene-specific therapeutics for inherited retinal diseases, with a particular focus on conditions such as retinitis pigmentosa, Leber congenital amaurosis, and genetic glaucoma. Through his work at the F.M. Kirby Center, he is committed to translating scientific findings into viable clinical applications to address the challenges of retinal diseases.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.